RSS Feed

Latest news

GP brand goes digital only - and new MIMS Learning magazine launches

GP brand goes digital only - and new MIMS Learning magazine launches

The last print issue of MIMS' sister publication GP...

Lynparza: new treatment option for ovarian cancer

Lynparza: new treatment option for ovarian cancer

Olaparib (Lynparza) is an inhibitor of human poly (ADP-ribose)...

Elvanse Adult launched for ADHD in adults

Elvanse Adult launched for ADHD in adults

Lisdexamfetamine is now available as Elvanse Adult...

Opdivo: first in new class of checkpoint inhibitors for melanoma

Opdivo: first in new class of checkpoint inhibitors for melanoma

Bristol-Myers Squibb has launched Opdivo (nivolumab)...

Cardiovascular warning for high-dose ibuprofen

Cardiovascular warning for high-dose ibuprofen

The cardiovascular risk associated with high doses...


New and deleted products

Promo Image

New Products

Products added to MIMS.

Promo Image

Deleted Products

Products removed from MIMS.


Most popular

Switching and Withdrawing Antidepressants

Quick-reference guide to switching and withdrawing...

H.pylori: Eradication Regimens (NICE)

Summary of NICE guidance for treatment of Helicobacter...

Cystitis

Vaginal Infections

Summary of Antibiotic Treatments in Adults

Dose regimens for common bacterial infections.


Featured MIMS resources

Lice and Scabies Treatments   

Pediculicides and scabicides: comparison of preparations and regimens.

Management of Hypertension

Diagnosis and treatment of high blood pressure, as recommended by NICE.


Patient fact sheets

Browse the MIMS patient fact sheet library and find printable patient information on topics from acne to yellow fever.

Acromegaly

ADHD

Fibroids


Manufacturers

Manufacturers

Contact details and drug listings for manufacturers in MIMS


New products coming soon to MIMS

Check back soon to find MIMS listings for the following new drugs:

Abasaglar (insulin glargine)

Akynzeo (netupitant/palonosetron)

Bramox (midodrine)

Catephen (Camellia sinensis extract)

Kengrexal (cangrelor)

Moventig (naloxegol)

Ofev (nintedanib)

Orbactiv (oritavancin)

Spiolto Respimat (tiotropium/olodaterol)

Toujeo (insulin glargine)


Latest from MIMS Dermatology

Static mattresses and pressure ulcers

The American College of Physicians has published two...

Infliximab biosimilar for psoriasis

Remsima (infliximab), an anti-inflammatory biologic...

Treatment for urticaria in Scotland

The Scottish Medicines Consortium has recommended the...


MIMS Clinics

Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.




Register for MIMS

Want to keep getting your free copy of MIMS? GPs will need to renew their subscription to keep receiving MIMS and GP for free in 2015. You can do this online now – take 2 minutes, and make sure you keep your free MIMS access!

Register

MIMS bulletins

News and updates straight to your inbox.

Prescribing Update: Fortnightly news bulletin
Spotlight: Disease-themed monthly round-up

Sign me up

MIMS Dermatology

Read the latest issue online exclusively on MIMS.

Read MIMS Dermatology

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases

Promo Image

Clinical calculators

Handy calculators and conversions for primary care.